Skin Cancer Clinical Trials

Immunotherapy trials are among the most active areas for melanoma. PD-1 inhibitors, combination checkpoint therapy, and new targets are all in active trials — many for patients who have already received prior treatment.

Surgery-free trials exist for BCC and SCC. Some are testing whether immunotherapy alone can replace surgery for certain squamous cell cancers — real options worth knowing about.

Prevention trials are available for high-risk patients — those with multiple prior skin cancers. These often involve simple interventions like vitamins, sunscreen protocols, or monitoring strategies.